SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-20-015941
Filing Date
2020-06-26
Accepted
2020-06-26 15:56:51
Documents
3
Group Members
BOREALIS CAPITAL PARTNERS III, LLCBOREALIS CAPITAL PARTNERS IV, LLCBOREALIS GRANITE FUND, L.P.VOX HEALTH FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea123487-13dferneau_compass.htm SC 13D 142693
2 JOINT FILING AGREEMENT ea123487ex99-1_compass.htm EX-99.1 4396
3 FORM OF LOCK-UP AGREEMENT ea123487ex99-2_compass.htm EX-99.2 67830
  Complete submission text file 0001213900-20-015941.txt   216394
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90878 | Film No.: 20993971
SIC: 6770 Blank Checks

Mailing Address 10 ALLEN STREET HANOVER NH 03755
Business Address
Ferneau Philip (Filed by) CIK: 0001814202 (see all company filings)

Type: SC 13D